Dulaglutide (Trulicity) will be listed on the PBS from 1 June for the treatment of type 2 diabetes mellitus, the Federal Minister for Health Greg Hunt has announced. The listing of the GLP-1 receptor agonist follows a successful application by Eli Lilly for the 1.5mg once weekly injection to be subsidised for the treatment of ...
Dulaglutide available on PBS for T2D from 1 June
By Michael Woodhead
30 May 2018